Concepedia

Biomarker-based Targeting

Biomarker-Based Targeting is a precision medicine strategy that uses measurable biological indicators to identify and selectively modulate molecular targets in disease pathways for therapeutic intervention.

60

Publications

3.4K

Citations

463

Authors

234

Institutions

Publications per year

2017–2026

34

Parents

Publications

60

The BATTLE Trial: Personalizing Therapy for Lung Cancer

Edward S. Kim, Roy S. Herbst, Ignacio I. Wistuba et al. · Cancer Discovery · 2011 · 893 citations

, , +17

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial

Yi-Zhou Jiang, Yin Liu, Yi Xiao et al. · Cell Research · 2020 · 314 citations · Full text

, , +16

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

Roy S. Herbst, David R. Gandara, Fred R. Hirsch et al. · Clinical Cancer Research · 2015 · 240 citations · Full text

, , +17

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

M. Mrabet, Olivier Cabaud, Emmanuelle Josselin et al. · Annals of Oncology · 2016 · 172 citations · Full text

, , +16

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer

Thomas Powles, Danielle Carroll, Simon Chowdhury et al. · Nature Medicine · 2021 · 116 citations

, , +15

1–5 of 60

Authors

463

  1. RS
    Roy S. Herbst

    The University of Texas MD Anderson Cancer Center, United States

    6 publications · 1.3K citations

    6

    h-index

  2. II
    Ignacio I. Wistuba

    The University of Texas MD Anderson Cancer Center, United States

    4 publications · 1K citations

    4

    h-index

  3. DJ
    David J. Stewart

    The University of Texas MD Anderson Cancer Center, United States

    4 publications · 1K citations

    4

    h-index

  4. GR
    George R. Blumenschein

    The University of Texas MD Anderson Cancer Center, United States

    4 publications · 1K citations

    4

    h-index

  5. CA
    Christine Alden

    The University of Texas MD Anderson Cancer Center, United States

    4 publications · 1K citations

    4

    h-index

1–5 of 463

Institutions

234

  1. Inserm

    Paris, France

    5 h-index

    44 publications

    4.1K citations

  2. The University of Texas MD Anderson Cancer Center

    Houston, United States

    5 h-index

    63 publications

    23.6K citations

  3. Yale Cancer Center

    New Haven, United States

    5 h-index

    33 publications

    2.3K citations

  4. University of California, Los Angeles

    Los Angeles, United States

    4 h-index

    8 publications

    384 citations

  5. Emory University

    Atlanta, United States

    3 h-index

    19 publications

    900 citations

  6. Vall d'Hebron Hospital Universitari

    Barcelona, Spain

    3 h-index

    3 publications

    193 citations

  7. AstraZeneca (United Kingdom)

    Cambridge, United Kingdom

    3 h-index

    14 publications

    1K citations

  8. Institut Paoli-Calmettes

    Marseille, France

    3 h-index

    6 publications

    836 citations

1–8 of 234

Venues

  1. Annals of Oncology

    4 publications · 284 citations

    4

    h-index

  2. Nature Medicine

    2 publications · 161 citations

    2

    h-index

  3. Cancer Discovery

    2 publications · 928 citations

    2

    h-index

  4. 2

    h-index

  5. Clinical Cancer Research

    2 publications · 304 citations

    2

    h-index

1–5